- Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity
- Unraveling progressive verbal memory deficits in Huntington's disease: insights from the LASSI-L
- ASO targets DNA repair protein to combat Huntington disease
- Downregulation of Pten Improves Huntington's Disease Phenotype by Reducing Htt Aggregates and Cell Death
- Protective effects of diacerein against quinolinic acid-induced Huntington's disease-like symptoms in adult zebrafish by targeting GSK-3beta signalling
- Spiritual Well-Being and Phenoconversion in Huntington's Disease: Analysis from the Prospective Huntington at Risk Observational Study
- Nonlinear Assessment of Gait Signal Complexity in Neurodegenerative Disorders
- Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice
- Unnatural foldamers as inhibitors of Aβ aggregation <em>via</em> stabilizing the Aβ helix
- Allelic Diversity, de novo CAG Expansions, and Intergenerational Instability at the HTT Locus in a clinical sample of Huntingtons Disease from India
- Action impulsivity and attention deficits in patients at an early stage of Huntington disease
- Sleep fragmentation, 24-hr rest-activity patterns, and cognitive function in premanifest Huntington's disease: An actigraphy study
- CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
- Topological Gait Analysis: A New Framework and Its Application to the Study of Human Gait
- Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
- Daily variation in symptoms and functioning in Huntington disease: Feasibility and variability
- Synergistic neuroprotective and cognitive-enhancing effects of Walnut Peptide and Theanine in human brain organoid and mouse stress models
- The effect of a single session of tDCS on attention in pediatric acquired brain injury: Characterising inter-individual structural and functional network response variability
- Recent Progress of Triplex DNA Formation and Its Applications
- Neuraxial Analgesia and Anesthesia for Labor and Cesarean Delivery in a Patient with Juvenile Huntington Disease: A Case Report
- Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis
- Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFqB in neurodegenerative disease
- Tandem repeat expansions and copy number variations as risk factors and diagnostic tools for amyotrophic lateral sclerosis
- Upcoming meetings related to Huntington's disease
- Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
- The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3beta inhibition
- MIMI-ONET: Multi-Modal image augmentation via Butterfly Optimized neural network for Huntington DiseaseDetection
- The Role of MicroRNAs in Neurodegeneration: Insights from Huntington's Disease
- The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders
- Inositol Phosphates and Synthesizing Enzymes: Implications in Neurodegenerative Disorders
- Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases
- Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
- The Role of Amphibian AMPs Against Oxidative Stress and Related Diseases
- Analysis of Short Tandem Repeat Expansions in a Cohort of 12,496 Exomes from Patients with Neurological Diseases Reveals Variable Genotyping Rate Dependent on Exome Capture Kits
- Transcriptome Study in Sicilian Patients with Huntington's Disease
- Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective
- Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease
- Endothelial Dysfunction in Huntington's Disease: Pathophysiology and Therapeutic Implications
- Pepinemab: a SEMA4D antagonist for treatment of Huntington's and other neurodegenerative diseases
- Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
- Combining Sampling Methods with Attractor Dynamics in Spiking Models of Head-Direction Systems
- Using wearable sensors and machine learning to assess upper limb function in Huntington's disease
- Mitochondrial Dysfunction in Neurodegenerative Diseases
- Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypes
- Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders
- Combination therapy of mitochondria-targeted antioxidants and polyphenols for early intervention in Huntington's disease
- Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons
- Recognizing familial Huntington's disease in an Asian cohort: Insights from the Philippines
- Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
- A spatial transcriptomics atlas of live donors reveals unique zonation patterns in the healthy human liver
- 'SpikeNburst' and 'Nicespike': Advanced Tools for Enhancing and Accelerating In Vitro High-Density Electrophysiology Analysis
- Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington's disease
- Specific contribution of cognitive and motor impairments with functional capacity and dependence in Huntington's disease
- Genetic therapies for movement disorders - current status
- Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) database
- Multiple Copper Ions Bind to and Promote the Oligomerization of Huntingtin Protein with Nonpathological Repeat Expansions
- Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications
- Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin
- Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
- Optogenetic restoration of neuron subtype-specific cortical activity ameliorates motor deficits in Huntington's Disease mice
- Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale
- Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention
- Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease
- Quality of care through the eyes of residents with Huntington's disease living in a nursing home: A qualitative explorative study
- Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimaging
- Huntington's disease at work: The effect of profession-specific requirements as related to clinical characteristics on work outcome
- Frequency of depression in Huntington's disease: A systematic review and meta-analysis
- Sleep-wake cycle and 24-h motor activity in early-mid Huntington's disease patients: An actigraphy-based study
- Study protocol for the iMarkHD study in individuals with Huntington's disease
- Through their eyes: A retrospective mixed-methods study on the experiences and support needs of children growing up with a parent with Huntington's disease
- Mortality trends and disparities in adults with Huntington's disease in the United States
- Huntington's Disease Clinical Trials Update: September 2024
- Are people living with Huntington's disease experiencing person-centered integrated care?
- Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases
- Exploring relationships among gait, balance, and physical activity in individuals with Huntington's disease
- Antidopaminergic medications in Huntington's disease
- Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation
- Upcoming meetings related to Huntington's disease
- Economic burden of Huntington's disease: A systematic review
- Anxiety, memory, and social impairments in the YAC128 mouse model of Huntington's disease
- Neuroimaging Techniques in Huntington's Disease: A Critical Review
- Huntington's Disease in Hospitalized Patients Infected with SARS-CoV-2 in Brazil: Three-Year Update
- Glycosphingolipids in neurodegeneration - Molecular mechanisms, cellular roles, and therapeutic perspectives
- Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorders and Long COVID
- Navigating competing needs: a qualitative study on parenthood with a partner with Huntington's disease
- A narrative review of phase III and IV clinical trials for the pharmacological treatment of Huntington's disease in adults
- PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model
- CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology
- Healthcare delay in neurogenetic disorders of adult onset and the role of predictive genetic testing
- Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
- Unbiased human genomic characterization of polyglutamine disorder genes to inform therapeutic strategies
- MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges
- Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
- Evaluating Determinants of Length of Stay in Burn Care: Is One Day per 1% Total Burn Surface Area Still Accurate?
- The roles of intrinsically disordered proteins in neurodegeneration
- Dental Calculus Formation Rate: The Role of Salivary Proteome and Metaproteome
- Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders
- Tracing the evolution and genomic dynamics of mating-type loci in Cryptococcus pathogens and closely related species
- Evaluation of GFM1 mutations pathogenicity through in silico tools, RNA sequencing and mitophagy pahtway in GFM1 knockout cells
- Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities
